NCT04752098View on ClinicalTrials.gov

A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Metabolic Bone DiseaseOsteopeniaNeonatal Rickets
Interventions
DIAGNOSTIC_TEST

Vibro-acoustic analysis (VAA), based on ultrasound radiation force

The study will develop and validate a new ultrasonic method for assessment of infant bone by evaluating structural and mechanical characteristics of the infant tibia. This project will utilize a novel, non-invasive method, vibro-acoustic analysis (VAA), to evaluate infant bone properties in a wide frequency range while reducing the artifacts from soft tissue.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Mayo Clinic

OTHER

NCT04752098 - A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method | Biotech Hunter | Biotech Hunter